Company Filing History:
3 out of 1,743 
2 out of 3,559 
1 out of 1 
Years Active: 2010-2013
Title: Didier Job: Innovator in Neuropharmacology
Introduction
Didier Job is a prominent inventor based in Grenoble, France. He has made significant contributions to the field of neuropharmacology, particularly in the treatment of neuronal connectivity defects. With a total of 3 patents, his work focuses on innovative approaches to address complex neurological disorders.
Latest Patents
One of Didier Job's latest patents is titled "Use of epothilones in the treatment of neuronal connectivity defects such as schizophrenia and autism." This invention involves the use of at least one epothilone or its derivative as an active ingredient for manufacturing a medicament aimed at treating diseases associated with neuronal connectivity defects. Another notable patent is "Transgenic or recombinant non-human mammals and their uses in screening psychoactive medicines." This invention concerns transgenic or recombinant non-human mammals, wherein the expression of the gene coding for a microtubule-associated protein (MAP) is modified. This modification allows for the screening of medicines useful in treating schizophrenia and schizo-affective disorders, which may include anxious, paranoid, or depressive components.
Career Highlights
Didier Job has worked with esteemed organizations such as the Institut National de la Santé et de la Recherche Médicale and the Commissariat à l'Énergie Atomique. His experience in these institutions has allowed him to advance his research and contribute to the development of innovative treatments in neuropharmacology.
Collaborations
Throughout his career, Didier has collaborated with notable colleagues, including Annie Andrieux and Annie Schweitzer. These partnerships have fostered a collaborative environment that enhances the research and development of new therapeutic approaches.
Conclusion
Didier Job's innovative work in neuropharmacology, particularly through his patents and collaborations, highlights his commitment to advancing treatments for complex neurological disorders. His contributions are paving the way for new therapeutic options in the field.